Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Erythromycin ethylsuccinate
Drug ID BADD_D00805
Description Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of [Azithromycin], [Clarithromycin], [Spiramycin] and others. It was originally discovered in 1952.[L5245] Erythromycin is widely used for treating a variety of infections, including those caused by gram-positive and gram-negative bacteria.[L5245,L7261] It is available for administration in various forms, including intravenous, topical, and eye drop preparations.[L5245]
Indications and Usage For use in the treatment of infections caused by susceptible strains of microorganisms in the following diseases: respiratory tract infections (upper and lower) of mild to moderate degree, pertussis (whooping cough), as adjunct to antitoxin in infections due to Corynebacterium diphtheriae, in the treatment of infections due to Corynebacterium minutissimum, intestinal amebiasis caused by Entamoeba histolytica, acute pelvic inflammatory disease caused by Neisseria gonorrhoeae, skin and soft tissue infections of mild to moderate severity caused by Streptococcus pyogenes and Staphylococcus aureus, primary syphilis caused by Treponema pallidum, infections caused by Chlamydia trachomatis, nongonococcal urethritis caused by Ureaplasma urealyticum, and Legionnaires' disease caused by Legionella pneumophila.
Marketing Status Prescription; Discontinued
ATC Code D10AF02; J01FA01; S01AA17
DrugBank ID DB00199
KEGG ID D01361
MeSH ID D015643
PubChem ID 443953
TTD Drug ID Not Available
NDC Product Code 24338-130; 24338-110; 24338-132; 62559-440; 62559-630; 52536-136; 12836-0305; 24338-100; 46708-887; 52536-132; 51927-3116; 52536-130; 50546-399; 52536-134; 62559-631; 24338-136; 52334-003; 63629-2500; 24338-134; 50546-401
Synonyms Erythromycin Ethylsuccinate | Ethylsuccinate, Erythromycin | Eyrthromycin Ethyl Succinate | Ethyl Succinate, Eyrthromycin | Succinate, Eyrthromycin Ethyl | EryPed | Wyamycin E | Monomycin | Pediamycin | E-Mycin E | EMycin E | Erythroped
Chemical Information
Molecular Formula C43H75NO16
CAS Registry Number 1264-62-6
SMILES CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N( C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Deafness04.02.01.001--Not Available
Diarrhoea07.02.01.001--
Electrocardiogram QT prolonged13.14.05.004--
Erythema multiforme23.03.01.003; 10.01.03.015--
Gastrointestinal pain07.01.05.005--
Hepatic function abnormal09.01.02.001--Not Available
Hepatitis09.01.07.004--Not Available
Hypersensitivity10.01.03.003--
Liver function test abnormal13.03.01.013--Not Available
Nausea07.01.07.001--
Pancreatitis07.18.01.001--
Pseudomembranous colitis11.02.02.002; 07.19.01.003--Not Available
Rash23.03.13.001--Not Available
Seizure17.12.03.001--
Stevens-Johnson syndrome11.07.01.005; 10.01.03.020; 23.03.01.007; 12.03.01.014--
Torsade de pointes02.03.04.005--Not Available
Toxic epidermal necrolysis23.03.01.008; 12.03.01.015; 11.07.01.006; 10.01.01.006--
Urticaria10.01.06.001; 23.04.02.001--
Ventricular arrhythmia02.03.04.006--
Ventricular tachycardia02.03.04.010--
Vomiting07.01.07.003--
Hypoacusis04.02.01.006--
Epidermal necrosis23.03.03.035--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
The 1th Page    1    Total 1 Pages